Amarin Corporation plc ADR (AMRN)
NASDAQ
Delayed Data
Oct 23, 2026, 01:30 PM
Day's Range
11.4052 wk Range
11.25Overview - AMRN - Amarin Corporation plc ADR
Key Statistics
Valuation
Enterprise Value
-63.92M
P/E (Trailing)
-6.40
P/E (Forward)
11.81
PEG Ratio
0.19
Price / Sales (TTM)
1.30
Price / Book
0.54
EV / EBITDA
3.03
Profitability
Gross Margin
35.50%
Profit Margin
-14.56%
Operating Margin
-28.35%
Return on Assets
-2.31%
Return on Equity
-5.97%
Ownership
Shares Outstanding
420.04M
Float
19.41M
Short % of Shares Outstanding
2.55%
Held by Insiders
37.18%
Held by Institutions
20.77%
Price stats
Beta
0.76
50-Day Avg
13.63
200-Day Avg
14.50
Dividends
Payout Ratio
0.00%
Analyst Consensus
2 analysts
Shariah Compliance
Report Date: Feb 16, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AMRN - Amarin Corporation plc ADR
Peers - AMRN - Amarin Corporation plc ADR
Peer Comparison
Compared with companies in Drug Manufacturers - General listed on NASDAQ.
- AMRNNASDAQAmarin Corp PLC242.82MMarket Cap-72.45%52-week change-6.41P/E (Trailing)-14.56%Profit Margin
- AZNNASDAQAstraZeneca PLC American Depositary Shares256.53BMarket Cap-1.41%52-week change23.77P/E (Trailing)17.02%Profit Margin
- AMGNNASDAQAmgen Inc. Common Stock237.30BMarket Cap+31.39%52-week change26.39P/E (Trailing)22.95%Profit Margin
- GILDNASDAQGilead Sciences, Inc.189.79BMarket Cap+18.94%52-week change17.87P/E (Trailing)-10.63%Profit Margin
- SNYNASDAQSanofi ADR95.22BMarket Cap-22.80%52-week change21.20P/E (Trailing)8.09%Profit Margin
- ROPNASDAQRoper Technologies Inc.43.33BMarket Cap-5.84%52-week change17.34P/E (Trailing)30.71%Profit Margin
- BIIBNASDAQBiogen Inc.33.89BMarket Cap+36.93%52-week change40.09P/E (Trailing)8.32%Profit Margin
Profile Summary - AMRN - Amarin Corporation plc ADR
About
Amarin Corporation plc ADR is a biopharmaceutical company focused on cardiovascular health. Its commercial activities center on developing and marketing therapies for patients with elevated triglycerides and other cardiovascular risk factors, with Vascepa as its primary marketed product. The company serves healthcare…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
